An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million ...

Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and ...

A groundbreaking HIV cure trial conducted in Durban has demonstrated promising results in achieving antiretroviral therapy (ART)-free virus control. The trial shows that 20% of participants remain off ...

Vaccines, medications and other biomedical breakthroughs are necessary to eliminate epidemic diseases. But as I explore in my ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...

"They are a threat to the lives of countless individuals who rely on the science and the research to live. This is a matter of life and death. For many people living with HIV, particularly in ...

As scientists gathered at the Conference for Retroviruses and Opportunistic Infections, or CROI, for meetings that run through Wednesday, they face an uncertain future. It was evident in who was ...

The National Science Foundation has begun reviewing active ... The Centers for Disease Control and Prevention took down resources for HIV prevention, LGBTQ+ health, contraception, and more ...